Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Deferred Tax: 2011-2024

Historic Long-Term Deferred Tax for Ligand Pharmaceuticals (LGND) over the last 13 years, with Dec 2024 value amounting to $72,000.

  • Ligand Pharmaceuticals' Long-Term Deferred Tax rose 12112.82% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 12112.82%. This contributed to the annual value of $72,000 for FY2024, which is 66.36% down from last year.
  • As of FY2024, Ligand Pharmaceuticals' Long-Term Deferred Tax stood at $72,000, which was down 66.36% from $214,000 recorded in FY2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Long-Term Deferred Tax peaked at $35.7 million during FY2021, and registered a low of $72,000 during FY2024.
  • Moreover, its 3-year median value for Long-Term Deferred Tax was $214,000 (2023), whereas its average is $2.9 million.
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first skyrocketed by 46.91% in 2021, then tumbled by 97.49% in 2023.
  • Yearly analysis of 5 years shows Ligand Pharmaceuticals' Long-Term Deferred Tax stood at $24.3 million in 2020, then spiked by 46.91% to $35.7 million in 2021, then crashed by 76.13% to $8.5 million in 2022, then slumped by 97.49% to $214,000 in 2023, then plummeted by 66.36% to $72,000 in 2024.